The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Bovaclox DC Intramammary Suspension

500, 250 mg/syringe Intramammary suspension

Norbrook Laboratories (Ireland) LimitedVPA22664/005/001

Main Information

Trade NameBovaclox DC Intramammary Suspension
Active SubstancesCloxacillin
Strength500, 250 mg/syringe
Dosage FormIntramammary suspension
Licence HolderNorbrook Laboratories (Ireland) Limited
Licence NumberVPA22664/005/001

Group Information

ATC CodeQJ51RC Beta-lactam antibacterials, penicillins, combinations with other antibacterials
Therapeutic ClassAntibacterial


Licence Issued01/10/1987
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back